Callio Therapeutics
PrivateLast Round
Series A
Mar 3, 2025
Total Funding Raised
$187M
Momentum Score
75 /100
Company Overview
Callio Therapeutics is a biotechnology company that develops next-generation, multi-payload antibody-drug conjugates (ADCs) for cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Callio Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Callio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 3, 2025 |
Key People
Founding team and executive leadership
Callio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A |
| SEEDS Capital | Series A |
| ClavystBio | Series A |
| EDBI | Series A |
| Norwest Venture Partners | Series A |
| Frazier Life Sciences | Series A |
| Novo Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Apr 20, 2026
Monthly visitors increased 500% MoM.
Callio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Callio Therapeutics's valuation, stock price, and market status.
